Wednesday, July 8, 2026

pharma · Acute Cannabinoid Intoxication · ANEB

Anebulo Pharmaceuticals

Anebulo Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Austin, USA HQ
10 Employees
Public company Type
ANEB · NYSE Ticker
Company details
Status
Public
HQ
Austin, USA
Employees
10
Programs
2
Drugs
0
Patents
1
Intelligence · Drug Pipeline

Anebulo Pharmaceuticals pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Anebulo Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →